Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Cytoskeleton / ECM Cytoskeleton Intermediate Filaments Class I Cytokeratins

Human KRT8 (Cytokeratin 8) knockout HeLa cell pellet (ab279069)

Price and availability

670 ₸

Availability

Order now and get it on Tuesday March 09, 2021

Human KRT8 (Cytokeratin 8) knockout HeLa cell pellet (ab279069)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

You may also be interested in

Product image
Anti-Cytokeratin 19 antibody [LP2K] (ab254186)
Product image
FITC Anti-Cytokeratin 8 antibody [C-43] (ab176533)
Product image
Anti-Cytokeratin 10 antibody [RKSE60] (ab9025)
Product image
Anti-Cytokeratin 14 antibody (ab15461)

Properties

  • Storage instructions

    Store at -80°C. Please refer to protocols.
  • Components 1 kit
    Human KRT8 knockout HeLa cell pellet 1 vial
    Human wild-type HeLa cell pellet 1 vial
  • Research areas

    • Signal Transduction
    • Cytoskeleton / ECM
    • Cytoskeleton
    • Intermediate Filaments
    • Class I
    • Cytokeratins
    • Cancer
    • Invasion/microenvironment
    • ECM
    • Cell adhesion
    • Other
  • Cell type

    epithelial
  • Disease

    Adenocarcinoma
  • Gender

    Female
  • STR Analysis

    Amelogenin X D5S818: 11, 12 D13S317: 12, 13.3 D7S820: 8, 12 D16S539: 9, 10 vWA: 16, 18 TH01: 7 TPOX: 8, 12 CSF1PO: 9, 10

Images

  • Western blot - Human KRT8 (Cytokeratin 8) knockout HeLa cell pellet (ab279069)
    Western blot - Human KRT8 (Cytokeratin 8) knockout HeLa cell pellet (ab279069)

    Lane 1: A431 cell lysate (20 µg)

    Lane 2: MCF7 cell lysate (20 µg)

    Lane 3: Wild-type HeLa cell lysate (20 µg)

    Lane 4: KRT8 knockout HeLa cell lysate (20 µg)

    Lanes 1 - 4: Merged signal (red and green). Green - ab9023 observed at 55 kDa. Red - loading control, ab181602 observed at 37 kDa.  

    ab9023 was shown to react with Cytokeratin 8 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab255400 (knockout cell lysate ab263785) was used. Wild-type and Cytokeratin 8 knockout samples were subjected to SDS-PAGE. ab9023 and Anti-GAPDH antibody EPR16891] - Loading Control (ab181602) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed (ab216772) and Goat Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216777) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

  • Western blot - Human KRT8 (Cytokeratin 8) knockout HeLa cell pellet (ab279069)
    Western blot - Human KRT8 (Cytokeratin 8) knockout HeLa cell pellet (ab279069)

    Lane 1: A431 cell lysate (20 µg)

    Lane 2: MCF7 cell lysate (20 µg)

    Lane 3: Wild-type HeLa cell lysate (20 µg)

    Lane 4: KRT8 knockout HeLa cell lysate (20 µg)

    Lanes 1 - 4: Merged signal (red and green). Green - ab53280 observed at 55 kDa. Red - loading control, ab8245 observed at 37 kDa.  

    ab53280 was shown to react with Cytokeratin 8 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab255400 (knockout cell lysate ab263785) was used. Wild-type and Cytokeratin 8 knockout samples were subjected to SDS-PAGE. ab53280 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 10000 (For unpurified use at 1/25,000 - 1/50,000) dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

  • Sanger Sequencing - Human KRT8 (Cytokeratin 8) knockout HeLa cell pellet (ab279069)
    Sanger Sequencing - Human KRT8 (Cytokeratin 8) knockout HeLa cell pellet (ab279069)

    Allele-1: 4 bp deletion in exon 2

     

  • Sanger Sequencing - Human KRT8 (Cytokeratin 8) knockout HeLa cell pellet (ab279069)
    Sanger Sequencing - Human KRT8 (Cytokeratin 8) knockout HeLa cell pellet (ab279069)

    Allele-2: 2 bp deletion in exon 2

     

  • Sanger Sequencing - Human KRT8 (Cytokeratin 8) knockout HeLa cell pellet (ab279069)
    Sanger Sequencing - Human KRT8 (Cytokeratin 8) knockout HeLa cell pellet (ab279069)

    Allele-3: 1 bp insertion in exon 2

     

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Human Histone H3.3 (Mutated G34W, G34V, G34R) Antibody Panel (ab274410)

  •  
  • Product image

    Donkey Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed (ab150061)

  •  
  • Product image

    Anti-CD8 alpha antibody [CAL67] - BSA and Azide free (ab251597)

  •  
  • Anti-Hepatitis C Virus Core Antigen antibody [11-B3] (ab18929)

  •  
  • Anti-HSV2 gG Envelope antibody [H1206] (ab53470)

  •  
  • Product image

    Anti-Myc tag antibody [9E10] - BSA and Azide free (ab264603)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.